文献速递免疫规划

气溶胶递送辐照大肠杆菌可提供血清型非依赖性保护并预防幼鸡大肠杆菌病

Aerosol delivered irradiated Escherichia coli confers serotype-independent protection and prevents colibacillosis in young chickens.
PubMed 文献 · Vaccine · 2023-01-13

本研究首次评估γ射线辐照大肠杆菌经不同菌株和途径预防鸡大肠杆菌病的效果。辐照菌与未处理菌的细胞结构、代谢活性和蛋白谱相似。三次动物试验显示,气溶胶单次应用辐照菌可对同源和异源菌株攻击提供保护,且不引发抗体反应,提示先天或细胞免疫的重要性。

要点

  • 气溶胶单次应用辐照大肠杆菌对同源和异源菌株攻击均有效。
  • 气溶胶途径比眼鼻途径提供更好的保护。
  • 辐照大肠杆菌不引发抗体反应,提示先天或细胞免疫参与保护。

核心结论

  • 无佐剂单次气溶胶应用辐照「被杀灭但代谢活跃」的大肠杆菌在预防幼鸡早期大肠杆菌病方面显示出有希望的结果。

研究设计与样本

  • 首次研究γ射线辐照大肠杆菌预防鸡大肠杆菌病的效果,考虑不同菌株和应用途径;进行了三次动物试验,评估临床症状、病理病变和全身器官细菌定植。

主要发现

  • 电镜、alamarBlue法和MALDI-TOF质谱显示辐照与未处理的大肠杆菌PA14/17480/5-ovary(血清型O1:K1)的细胞结构、代谢活性和蛋白谱相似。
  • 第一次试验中,7日龄和21日龄分别经气溶胶和眼鼻途径给予辐照大肠杆菌PA14/17480/5-ovary,在同源攻击后预防病变发生和全身细菌播散,效果与活菌感染或甲醛灭活菌相当。
  • 第二次试验中,1日龄鸡单次气溶胶应用同一辐照菌株,对同源或异源菌株(未定义血清型)攻击均有效;气溶胶应用比眼鼻途径提供更好的保护。
  • 第三次试验显示对大肠杆菌PA15/19103-3(血清型O78:K80)有效,并再次确认同源保护结果;辐照PA15/19103-3菌株代谢活性较低,即使同源保护也较少被优选,强调疫苗菌株的重要性。
  • 所有试验中辐照大肠杆菌均未引发抗体反应,表明先天或细胞介导免疫对保护的重要性。

临床怎么用

  • 作者认为,无佐剂单次气溶胶应用辐照「被杀灭但代谢活跃」的大肠杆菌在预防幼鸡早期大肠杆菌病方面显示出有希望的结果。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Escherichia coli causes colibacillosis in chickens, which has severe economic and public health consequences. For the first time, we investigated the efficacy of gamma-irradiated E. coli to prevent colibacillosis in chickens considering different strains and application routes. Electron microscopy, alamarBlue assay and matrix assisted laser desorption/ionization time-of- flight mass spectrometry showed that the cellular structure, metabolic activity and protein profiles of irradiated and non-treated E. coli PA14/17480/5-ovary (serotype O1:K1) were similar. Subsequently, three animal trials were performed using the irradiated E. coli and clinical signs, pathological lesions and bacterial colonization in systemic organs were assessed. In the first animal trial, the irradiated E. coli PA14/17480/5-ovary administered at 7 and 21 days of age via aerosol and oculonasal routes, respectively, prevented the occurrence of lesions and systemic bacterial spread after homologous challenge, as efficient as live infection or formalin-killed cells. In the second trial, a single aerosol application of the same irradiated strain in one-day old chickens was efficacious against challenges with a homologous or a heterologous strain (undefined serotype). The aerosol application elicited better protection as compared to oculonasal route. Finally, in the third trial, efficacy against E. coli PA15/19103-3 (serotype O78:K80) was shown. Additionally, previous results of homologous protection were reconfirmed. The irradiated PA15/19103-3 strain, which also showed lower metabolic activity, was less preferred even for the homologous protection, underlining the importance of the vaccine strain. In all the trials, the irradiated E. coli did not provoke antibody response indicating the importance of innate or cell mediated immunity for protection. In conclusion, this proof-of-concept study showed that the non-adjuvanted single aerosol application of irradiated "killed but metabolically active" E. coli provided promising results to prevent colibacillosis in chickens at an early stage of life. The findings open new avenues for vaccine production with E. coli in chickens using irradiation technology.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Paudel S, Hess C, Kamal Abdelhamid M, et al. Aerosol delivered irradiated Escherichia coli confers serotype-independent protection and prevents colibacillosis in young chickens. Vaccine. 2023. PMID: 36642629. doi:10.1016/j.vaccine.2022.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。